Two Sigma Securities’s Halozyme HALO Stock Holding History

Two Sigma Securities’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,500	Closed	-$200K	–	2300
2024 Q3	$200K	Buy	+3,500	New	+$201K	﹤0.01%	2161
2020 Q1	–	Sell	-66,300	Closed	-$1.18M	–	1732
2019 Q4	$1.18M	Buy	66,300 +54,300	+453%	+$940K	0.01%	969
2019 Q3	$186K	Buy	12,000 +1,700	+17%	+$28K	﹤0.01%	1861
2019 Q2	$177K	Buy	+10,300	New	+$166K	﹤0.01%	1765

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Two Sigma Securities's HALO Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Halozyme (HALO) in Q2 2026: 12,525 shares worth $980K. The stake represents 0.08% of the portfolio and ranks #299 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in HALO as recently as Q2 2022.

Two Sigma Securities first reported a position in HALO in Q2 2022 and has held it in 2 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Two Sigma Securities held 12,525 shares of Halozyme worth $980K as of Q2 2026.
Halozyme was a new Two Sigma Securities position in Q2 2026.
Halozyme made up 0.08% of Two Sigma Securities's portfolio in Q2 2026, its #299 holding.
Two Sigma Securities first reported a position in Halozyme in Q2 2022 and has held it in 2 quarters since.
672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.